Publications by authors named "Kate Guilfoyle"

Claim this Profile
S
Susceptibility of calf lung slice cultures to H5N1 influenza virus.
Kate Guilfoyle, Monica Mirolo, Geert van Amerongen, Guido van der Net, Mara Sophie Lombardo

Emerg Microbes Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Pathogenic Avian Influenza Virus A/H5N1 Subclade 2.3.4.4b Isolated from a European Grey Seal (Halichoerus grypus) Is Highly Virulent in Ferrets.
Kate Guilfoyle, Monica Mirolo, Leon de Waal, Geert van Amerongen, Guido van der Net

J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syrian hamsters (Mesocricetus auratus) as an upper respiratory tract model for respiratory syncytial virus infection.
Sophie M Kolbe, Kate Guilfoyle, Wencke Reineking, Geert van Amerongen, Guido van der Net

Npj Viruses· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.
Wenjuan Du, Daniel L Hurdiss, Dubravka Drabek, Anna Z Mykytyn, Franziska K Kaiser, Kate Guilfoyle

Sci Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
Federico Armando, Georg Beythien, Franziska K Kaiser, Lisa Allnoch, Laura Heydemann, Kate Guilfoyle

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, James Barnes, Alberto A Amarilla, Kate Guilfoyle

NPJ Vaccines· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
Christopher L D McMillan, Stacey T M Cheung, Naphak Modhiran, James Barnes, Alberto A Amarilla, Kate Guilfoyle

NPJ Vaccines· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
Kate Guilfoyle, Diane Major, Sarah Skeldon, Heather James, Jeanette L Tingstedt

Vaccine· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.
Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, Francesca L Mordant, Zheyi Li, Kate Guilfoyle

Clin Transl Immunology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models for COVID-19.
César Muñoz-Fontela, William E Dowling, Simon G P Funnell, Pierre-S Gsell, A Ximena Riveros-Balta, Kate Guilfoyle

Nature· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets.
Leena R Yeolekar, Kate Guilfoyle, Milan Ganguly, Parikshit Tyagi, Koert J Stittelaar

Vaccine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.
Yoshita Bhide, Wei Dong, Inta Gribonika, Daniëlle Voshart, Tjarko Meijerhof, Kate Guilfoyle

Front Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Wei Dong, Yoshita Bhide, Federica Sicca, Tjarko Meijerhof, Kate Guilfoyle

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
Othmar G Engelhardt, Chantal Edge, Una Dunleavy, Kate Guilfoyle, Ruth Harvey

Vaccine· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.
Rebecca J Cox, Diane Major, Gabriel Pedersen, Rishi D Pathirana, Katja Hoschler, Kate Guilfoyle

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
Diane Major, Jessica A Chichester, Rishi D Pathirana, Kate Guilfoyle, Yoko Shoji

Hum Vaccin Immunother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs.
Carolyn Nicolson, Ruth Harvey, Rachel Johnson, Kate Guilfoyle, Othmar G Engelhardt

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.
Ruth Harvey, Kate A Guilfoyle, Sarah Roseby, James S Robertson, Othmar G Engelhardt

J Virol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of vaccine viruses against pandemic A(H1N1) influenza.
James S Robertson, Carolyn Nicolson, Ruth Harvey, Rachel Johnson, Diane Major, Kate Guilfoyle

Vaccine· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.
Ruth Harvey, Carolyn Nicolson, Rachel E Johnson, Kate A Guilfoyle, Diane L Major

Vaccine· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis